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Vascular Smooth Muscle Sirtuin-1 Protects Against Aortic Dissection
During Angiotensin II–Induced Hypertension
Jessica L. Fry, PhD;* Yasunaga Shiraishi, PhD;* Rapha€el Turcotte, PhD; Xunjie Yu, BSc; Yuan Z. Gao, PhD; Rachid Akiki, MD;
Markus Bachschmid, PhD; Yanhang Zhang, PhD; Kathleen G. Morgan, PhD; Richard A. Cohen, MD; Francesca Seta, PhD
Background-—Sirtuin-1 (SirT1), a nicotinamide adenine dinucleotide+–dependent deacetylase, is a key enzyme in the cellular
response to metabolic, inflammatory, and oxidative stresses; however, the role of endogenous SirT1 in the vasculature has not
been fully elucidated. Our goal was to evaluate the role of vascular smooth muscle SirT1 in the physiological response of the aortic
wall to angiotensin II, a potent hypertrophic, oxidant, and inflammatory stimulus.
Methods and Results-—Mice lacking SirT1 in vascular smooth muscle (ie, smooth muscle SirT1 knockout) had drastically high
mortality (70%) caused by aortic dissection after angiotensin II infusion (1 mg/kg per day) but not after an equipotent dose of
norepinephrine, despite comparable blood pressure increases. Smooth muscle SirT1 knockout mice did not show any abnormal
aortic morphology or blood pressure compared with wild-type littermates. Nonetheless, in response to angiotensin II, aortas from
smooth muscle SirT1 knockout mice had severely disorganized elastic lamellae with frequent elastin breaks, increased oxidant
production, and aortic stiffness compared with angiotensin II–treated wild-type mice. Matrix metalloproteinase expression and
activity were increased in the aortas of angiotensin II–treated smooth muscle SirT1 knockout mice and were prevented in mice
overexpressing SirT1 in vascular smooth muscle or with use of the oxidant scavenger tempol.
Conclusions-—Endogenous SirT1 in aortic smooth muscle is required to maintain the structural integrity of the aortic wall in
response to oxidant and inflammatory stimuli, at least in part, by suppressing oxidant-induced matrix metalloproteinase activity.
SirT1 activators could potentially be a novel therapeutic approach to prevent aortic dissection and rupture in patients at risk, such
as those with hypertension or genetic disorders, such as Marfan’s syndrome. ( J Am Heart Assoc. 2015;4:e002384
doi: 10.1161/JAHA.115.002384)
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T he walls of large arteries are composed of 3 cell types:endothelial cells, vascular smooth muscle (VSM) cells,
and adventitial fibroblasts. Together with their underlying
extracellular matrix, these cells form an intricate network that
responds dynamically to hemodynamic changes and vasoac-
tive factors. Among these, angiotensin II (AngII), a peptide
hormone of the renin–angiotensin–aldosterone system, elicits
pleiotropic effects on the vasculature. AngII is a potent
vasoconstrictor signaling primarily through AngII receptor
type 1 (AT1R) to constrict resistance vessels and maintain
blood pressure in response to hypovolemia and increased
renin. In addition, AngII can elicit inflammation and remod-
eling of the aortic wall via generation of reactive oxygen
species (ROS), through activation of NADPH oxidases, and by
production of transforming growth factor b—responses that
are independent of AngII vasopressor effect on resistance
vessels.1 These combined signals produce a phenotypic
switch in the media and adventitia that results in medial
hypertrophy and collagen deposition, profoundly affecting the
mechanical properties of the aorta.2,3
ROS production in the aorta is increased in aging, diabetes,
and chronic inflammation—conditions associated with acti-
vation of the renin–angiotensin–aldosterone system—and it
contributes significantly to the pathogenesis of aortic
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diseases. In settings of increased endothelium-derived ROS,
moderate doses of AngII (1 mg/kg per day) are sufficient
to stimulate an inflammatory response in the murine
aorta, which activates elastin degradation by matrix
metalloproteinases (MMPs) in VSM, leading to aortic
dissection.4
Sirtuin-1 (SirT1; mammalian homolog of silent information
regulator in yeast) is a nicotinamide adenine dinucleotide+–
dependent deacetylase and a molecular target of polyphenols
and calorie restriction.5 SirT1 is generally associated with
beneficial metabolic effects6 by virtue of antioxidant7,8 and
anti-inflammatory9 effects; however, the role of SirT1 in the
vasculature is not fully elucidated. SirT1 deacetylates and
alters the function of key molecules involved in vascular
homeostasis; therefore, loss of SirT1 activity may be
detrimental to the vasculature. Lack of SirT1 in VSM in
apolipoprotein E–deficient mice exacerbates atherosclero-
sis,10 whereas VSM SirT1–overexpressing mice are resistant
to neointima formation in response to carotid artery liga-
tion.11 VSM SirT1 overexpression ameliorates medial hyper-
trophy in a model of AngII hypertension, concomitant with a
decrease in inflammation, via inhibition of nuclear factor jB
and transforming growth factor b.12
Because SirT1 is an attractive pharmaceutical target, it is
crucial to elucidate the role of endogenous SirT1 and
downstream signals in the vasculature. To this end, we
created a mutant mouse bearing a SirT1 deletion in VSM,
the major component of large elastic arteries (smooth
muscle SirT1 knockout [SMKO] mice). In this study, we
report that lack of VSM SirT1 results in high incidence of
aortic dissection in response to AngII-induced hypertension.
SMKO mice have baseline and blood pressure responses to
a-adrenergic agonists comparable to wild-type (WT) litter-
mates, and during a short course of AngII (1 mg/kg per
day), they become hypertensive, although to a lesser extent
than their WT counterparts. At baseline, vessel walls lacking
SirT1 in VSM have normal elastin structure and aortic
compliance; however, they display severely deranged elastic
fibers, increased MMP activity, and stiffness on exposure to
AngII, and 70% of SMKO mice die of aortic dissection within
14 days. Taken together, these data demonstrate a crucial
role of VSM SirT1 in the maintenance of vascular wall
integrity in response to AngII and provide a unique model of
aortic dissection.
Materials and Methods
VSM SMKO Mice
All animal experimental procedures were approved by the
institutional animal care and use committee at Boston
University Medical Campus. Floxed SirT1 mice on a C57Bl/
6J genetic background in which 2 loxP sites flank SirT1 exon
4, a critical exon required for the enzyme catalytic activity,
were obtained from David Sinclair at Harvard University
(Cambridge, MA). Floxed SirT1ex4 mice were bred with a Cre-
recombinase transgenic mouse in which Cre-recombinase
expression is driven by the endogenous smooth muscle 22a
protein (SM22a; transgelin) promoter (endogenous locus
SM22a Cre Knock-In; B6.129S6 Taglntm2(cre)Yec/J; Jackson
Laboratories), generating a mouse with SirT1 exon 4 deletion
in VSM (SMKO). Similarly, mice overexpressing SirT1 in VSM,
(SMTg), were generated by intercrossing a transgenic mouse
in which the SirT1 gene is inserted downstream of the
collagen type I locus and preceded by loxP sites flanking a
stop codon (obtained from David Sinclair), with the SM22a-
Cre male mice described above. Cre-recombinase activity in
VSM cells removes the stop codon, allowing overexpression
of the SirT1 gene.
To confirm the specificity of SirT1 deletion or overexpres-
sion for the VSM, we intercrossed SM22a-Cre with Tomato
reporter mice (B6.Cg-Gt[ROSA]26Sortm9[CAG-tdTomato]Hze/
J; Jackson Laboratories). A fluorescently red Tomato protein is
constitutively expressed except in cells containing Cre
recombinase, in which enhanced green fluorescent protein
is expressed instead of red Tomato on removal of a stop
codon by the Cre-recombinase activity. Mice were housed in
the Boston University Laboratory Animal Science Center in
12-hour light/dark-cycle rooms and with food and water ad
libidum.
AngII-Induced Hypertension
WT, SMKO, and SMTg mice aged 8 weeks were implanted
subcutaneously with Alzet osmotic minipumps (model 1007D
or 1002 for 1 or 2 weeks of infusion, respectively) containing
1 mg/kg per day of AngII (item A9525; Sigma-Aldrich)
dissolved in 100 lL saline or 10 mg/kg per day of nore-
pinephrine (Sigma-Aldrich) dissolved in 100 lL saline contain-
ing 1 mmol/L ascorbate.
The occurrence of deaths and/or aortic dissections and
overall animal health were closely monitored and recorded
during AngII or norepinephrine administration.
The development of hypertension in response to AngII or
norepinephrine infusion was monitored by radiotelemetry
(Data Sciences International) in conscious, freely moving WT
(n=5) and SMKO (n=5) mice. Radiotelemetry hardware
included the Data Exchange Matrix, PhysioTel receivers
(RCP-1), and a calibrated ambient pressure reference monitor
(APR-1). Implantation of the wireless transmitters was
performed in sterile conditions, following the manufacturer’s
recommendations. Briefly, the pressure-sensing region
(4 mm) of the catheter (model TA11PA-C10) was situated in
the aortic arch via catheterization of the left carotid artery in
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isofluorane-anesthetized mice, and the transmitter body was
placed in a subcutaneous pocket in the right flank. Recordings
(1 every 4 minutes, 360 recordings per mouse per day)
started after complete recovery from surgery (1 to 2 weeks).
Data are expressed as meanSEM after averaging
360 recordings per day for each mouse.
Arterial Pressures and Stiffness Measured by
High-Fidelity Pressure Catheters
In addition to radiotelemetry, mean arterial pressure was
assessed in anesthetized WT and SMKO mice using a solid-
state high-fidelity pressure catheter (Mikro-tip catheter
transducers, SPR-1000; Millar Instruments) inserted in the
carotid artery. Ten minutes of stable pressure waveforms
were recorded at baseline and after a bolus administration of
phenylephrine (0.1 lg/g of body weight), through a P10
polyurethane tapered catheter (FunnelCath; Harvard Appara-
tus) inserted in the right jugular vein.
Pulse wave velocity, the standard in vivo measure of
arterial stiffness, was assessed by simultaneously recording
blood pressure waveforms from 2 locations along the aorta.
We used a dual-pressure catheter (1.4 French) interfaced with
an acquisition and analysis workstation (NIHem; Cardiovas-
cular Engineering) with 1 kHz of bandwidth and a 5-kHz
sampling rate. Briefly, saline- or AngII-treated mice were
deeply anesthetized with a ketamine–xylazine mixture and
kept recumbent on a heated pad (38°C). ECG was acquired
through needle electrodes with lead wires connected to an
acquisition system (PowerLab Animal BioAmp; ADInstru-
ments). The catheter was inserted in the left carotid artery
and then gently advanced into the aorta so that the first
pressure-sensing region was situated into the aortic arch
(proximal location) and the second 2.5 cm distally to obtain
stable pressure waveform recordings from both locations
simultaneously. The foot-to-foot transit time was assessed
automatically from signal-averaged proximal and distal pres-
sure waveforms over 20-second continuous recording using
the R-wave of ECG as a fiducial point and resynchronization of
sequential recordings (NIHem software v. 4.99; Cardiovascu-
lar Engineering). Pulse wave velocity was then calculated by
dividing the distance (2.5 cm) by the difference among the 2
arrival times (in milliseconds). A total of 21 pulse wave
velocity measurements were performed as follows: 4 in WT
saline-treated mice (WT/saline), 4 in SMKO saline-treated
mice (SMKO/saline), 5 in WT AngII-treated mice (WT/AngII),
and 8 in SMKO AngII-treated mice (SMKO/AngII). One AngII-
treated WT mouse died during surgery, and 4 AngII-treated
SMKO mice presented with aortic dissection at necropsy and
thus were excluded from further analysis. Pressure recordings
from surviving and nondissected mice (n=4 in each group)
were analyzed and computed in the group average.
Mechanical Properties of the Aorta (Ex Vivo
Stiffness Measurement)
Stiffness of thoracic aortas was assessed in nondissected,
viable aortic rings from saline- and AngII-treated WT and
SMKO mice (n=4, WT/saline; n=4, SMKO/saline; n=5, WT/
AngII; n=5, SMKO/AngII). High-frequency, low-amplitude-
length oscillations, which have negligible effects on the
function of the aortic rings, were used to assess ex vivo
stiffness, as described previously.13
Aortic Morphometry and Immunostaining
Adjacent thoracic aortic rings were incubated for 30 minutes in
nuclear stain (NucBlue; Life Technologies) and then captured
with a fluorescent microscope, together with autofluorescence
of elastin lamellae (NIS-Elements software; Nikon). A total of 15
to 20measurements of themedial thickness (distance between
external and internal elastic lamina) and diameter from 3 rings
for each mouse were averaged before calculating the mean of
each experimental group (n=8, WT/saline; n=7, SMKO/saline;
n=10, WT/AngII; n=7, SMKO/AngII).
Aortas from saline- or AngII-treated WT and SMKO mice
were snap-frozen in optimal cutting temperature compound
and sectioned on a cryotome at a thickness of 6 µm. To
evaluate elastin, aortic sections from the aortic root to the
infrarenal aorta for each mouse were stained using an elastin
staining kit (Accustain Elastin Stain; Sigma-Aldrich), based on
the Van Gieson methodology, and were qualitatively analyzed
in a blinded fashion by Dr Josenia Tan at Boston University
School of Medicine, Department of Pathology.
Multiphoton Microscopy for Label-Free Imaging
of Elastin Fibers
Elastin possesses an intrinsic 2-photon fluorescence that
enables label-free imaging in intact tissue.14–16 Freshly
excised aorta from saline- and AngII-treated WT and SMKO
mice (n=4, WT/saline; n=4, SMKO/saline; n=5, WT/AngII;
n=5, SMKO/AngII) were imaged on a custom-built multi-
photon scanning microscope. Aortas were submerged in
PBS on a glass slide, and a coverslip was placed on top.
Spacers were present on both side of arteries to ensure
they would not be deformed by the coverslip. The 2-photon
autofluorescence signal from elastin was detected at 525/
45 nm and generated with 65 mW of a mode-locked Ti:
sapphire laser at 800 nm (Maitai-HP; Spectra-Physics).
Second-harmonic generation from collagen at 400 nm
(417/80 nm) was also collected. Samples were imaged
at 3 locations over the length of the descending aorta.
Images were recorded at every 2 lm through the arterial
thickness.
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Elastin images were analyzed using the Directionality plug-in
in the imaging processing software FIJI (freely available at
www.nih.gov). This plug-in performs a Fourier component
analysis to evaluate the dispersion of the elastin signal, as
described in detail elsewhere.17,18 The dispersion represents
the variation in fiber orientation; therefore, an increase in
dispersion indicates a decrease in organization. Eight regions of
32932 lmhaving a unique main orientation were analyzed per
artery. The dispersion value, in degrees, was normalized to the
amount of fiber present in the analyzed region, another output
of the Directionality plug-in.
Aortic VSM Cell Isolation
Aortic VSM cells were isolated by enzymatic dissociation, as we
do routinely.19 Briefly, aortas from WT and SMKO mice were
removed, flushed with cold PBS supplemented with 1%
antibiotic-antimycotic (Anti-Anti; Gibco, Life Technologies),
and cleaned of periaortic fat. Cleaned aortas were then washed
in PBS and incubated at 37°C for 12 minutes in 3 mg/mL
collagenase II (Worthington) in serum-free DMEM. Adventitia
was removed manually and preserved at 80°C until Western
blot or quantitative reverse transcription polymerase chain
reaction (qRT-PCR), analysis. The medial layer was further
dissociated in 3 mg/mL collagenase and 1 mg/mL elastase at
37°C for 30 minutes with gentle agitation every 10 minutes.
Cells were centrifuged and resuspended in complete growth
medium (DMEM, 1 g/L glucose supplemented with 10% FBS
and 1% Anti-Anti) and used until passage 10.
Quantitative RT-PCR on Aortic Extracts
The mRNA expression of several genes of interest (SirT1 exon
4, AT1R, MMP2, MMP3, MMP9, MMP19, MYH11) in aortic and
VSM extracts was assessed using standard procedures. Briefly,
total RNA from aortas and VSM cells of WT and SMKOmice was
extracted with Trizol (Life Technologies), followed by chloro-
form separation and isopropanol precipitation. After total RNA
retrotranscription (High-Capacity RNA-to-cDNA Kit; Applied
Biosystems, Life Technologies), RNA expression of genes of
interest was analyzed by quantitative RT-PCR with verified
TaqMan assays multiplexed for b-actin (AB750 instrument;
Applied Biosystems). Relative mRNA quantitation was calcu-
lated by the ΔΔCt method, expressed as relative to controls
and normalized by b-actin, used as an endogenous control.
VSM Cell and Aortic Lysate Immunoprecipitation
and Western Blot
VSM cells from WT and SMKO mice were cultured in DMEM
containing 10% FBS and 1% Anti-Anti in triplicate tissue culture–
grade 10-cm dishes. VSM cells were dissolved in RIPA
buffer (200 lL/1 mg tissue; Cell Signaling Technology) sup-
plemented with protease inhibitor cocktail and trichostatin A
(5 lmol/L), as appropriate. After brief sonication (10 seconds,
39, on ice), protein concentration was assessed using the
Pierce BCA Protein Assay (Thermo Scientific), per the manufac-
turer’s instructions. For immunoprecipitation studies, equal
amounts of proteins were incubated overnight at 4°C with 2 lg
of an anti–acetyl lysine antibody immobilized to agarose beads
(ImmunoChem)with rotating agitation. Beadswere thenwashed
with PBS and 1% NP40 3 times before elution with Laemmli
buffer and Western blotting. To confirm effective deletion of
active SirT1 in VSM, whole aortas or media and adventitia,
separately, from saline- and AngII-treated WT and SMKO mice
were manually disrupted with a glass–glass homogenizer on ice
and dissolved in RIPA buffer, as described above.
VSM cell or aortic lysates and immunoprecipitated proteins
were resolved by SDS-PAGE (7.5% or 4% to 20% polyacrylamide
gels) and transferred to PVDF membranes (100 V, 120 min-
utes). Membranes were blocked in 5% nonfat milk in 1% Tween-
20 in PBS (PBS-T) for 1 hour and incubated with 1 of the
following antibodies overnight at 1:1000 dilution: SirT1 (item
ab110304; Abcam), SM22a (a kind gift from K.G.M.), p53 (item
2524; Cell Signaling Technologies), TIMP-1 (item ab38798;
Abcam), galectin-3 (item ab53082, Abcam), VCAM-1 (item
14694; Cell Signaling Technologies), and b-actin (item A5441;
Sigma-Aldrich). Membranes were then washed in PBS-T and
incubated with peroxidase-conjugated anti-mouse or anti-
rabbit antibodies (Cell Signaling Technologies) and exposed to
the chemiluminescent substrate ECL (GE Healthcare) to
visualize protein bands. Protein band intensities were quanti-
fied with ImageJ (National Institutes of Health, www.nih.gov),
averaging band intensities pertaining to the same experimental
group.
In-Gel Zymography
Whole aortas, from the aortic root to the common iliac
bifurcation, were dissected from saline- or AngII-treated WT,
SMKO, or SMTg mice (n=4 in each group) and cleaned of
periaortic fat. Aortas were divided into 8 equal parts and
cultured at 37°C in 50 lL DMEM overnight. In a subset of
experiments, freshly prepared tempol (10 mmol/L) was
added to DMEM. Aortas were then homogenized on ice with
100 lL lysis buffer (50 mmol/L Tris, 10 mmol/L CaCl2,
150 mmol/L NaCl, 1% Triton X-100, 0.1% SDS, 0.5% Brij 35,
0.05% azide pH 7.4) and centrifuged at 16100 g for
15 minutes to obtain the protein supernatant. Protein content
of the aortic lysates was determined with the BCA Protein
Assay (Thermo Scientific), per the manufacturer’s instruc-
tions. Equal amounts of aortic proteins and corresponding
cultured aortic medium from 4 aortic homogenates, 1 from
each experimental group for a total of 8 samples, were loaded
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into a 10% zymogram gel containing gelatin as MMP substrate
(item 161-1167; Bio-Rad) after mixing with zymogram loading
buffer (item161-0764; Bio-Rad). Protein separation was
carried out in SDS-containing buffer for 5 hours at 4°C.
SDS was then exchanged with Triton X-100 for 30 minutes at
room temperature by soaking the gels in zymogram renatu-
ration buffer (item161-0765; Bio-Rad), which was then
replaced by the zymogram development buffer (item 161-
0766; Bio-Rad) for 30 minutes at room temperature. After a
second change of fresh development buffer, the gels were
incubated for 2 days at 37°C and stained with 0.5%
Coomassie Brilliant Blue R-250 (item 161-0400; Bio-Rad)
dissolved in 40% methanol and 10% acetic acid for 1 hour.
Gels were then destained with 20% methanol and 5% acetic
acid. Gel images were captured by transillumination with a
scanner (Perfection 4990 Photo; Epson) at 48-bit color and
300-dpi resolution. White bright bands over a blue back-
ground were indicative of gelatin in-gel digestion by the
enzymatic activity of MMPs.
Oxidant Measurement by Dihydroethidine
Dihydroethidine (DHE) was used to assess oxidant levels in
VSM cells and fresh frozen aortic sections. In the presence of
oxidants, mainly superoxide anion, DHE is oxidized to
ethidium, which intercalates with nuclear DNA generating a
red fluorescent signal. DHE solution (10 mmol/L) was freshly
prepared in DMSO and diluted to 10 lmol/L working solution
in PBS. Tiron, a superoxide scavenger, was freshly prepared at
10 mmol/L working solution (pH 7.4) and used to confirm the
specificity of DHE fluorescence signal.
Aortas from saline- or AngII-treated WT and SMKO mice
were frozen in optimal cutting temperature compound and kept
at 80°C until sectioning in a cryotome at a thickness of
10 lm. Aortic sections were washed on ice with cold PBS and
incubated with DHE solution at 37°C for 45 minutes. A
sequential section from the same aorta was positioned onto
the same slide so that a tiron treatment (10 mmol/L, pH 7.4)
could be run in parallel. Sections were then washed in PBS and
coverslipped with Prolong Gold Antifade mounting medium
(Life Technologies). Digital images were captured with an
epifluorescent microscope (Nikon Eclipse 80i), a CDD camera
(DQ Qi Mc), and NIS-Elements 3.22 software (Nikon) and
scored for red fluorescence intensity by 4 independent
observers, blinded to the experimental groups. Scores pertain-
ing to the same experimental group were averaged (n=7, WT/
saline; n=5, SMKO/saline; n=5, WT/AngII; n=12, SMKO/
AngII).
VSM cells were obtained from WT and SMKO aortas, as
described above, cultured in triplicate 10-cm culture dishes
A
B
Figure 1. Novel mouse strain with SirT1 deletion in vascular smooth muscle (SMKO). A,
Specific genetic deletion of VSM SirT1 exon 4 confirmed by qRT-PCR on aortas (n=5, WT and
n=5, SMKO) and cultured VSM cells (n=3). SirT1 mRNA expression normalized to b-actin and
expressed as fold-change vs WT. *P<0.05 vs WT. B, Representative Western blot for WT and
exon 4/ SirT1 in aortic media from WT (n=4) and SMKO mice (n=4). Each lane represents
1 mouse. AngII indicates angiotensin II; ex, exon; qRT-PCR, quantitative reverse transcription
polymerase chain reaction; SirT1, sirtuin-1; SMKO, smooth muscle SirT1 knockout; VSM,
vascular smooth muscle; VSMC, vascular smooth muscle cells; WT, wild type.
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to 80% confluence and serum-starved overnight before
treatment with AngII (100 nmol/L, 6 hours) or vehicle
(PBS) in the presence of DHE or DHE plus tiron. At the end
of the treatment period, VSM cells were washed in
Hanks’ balanced salt solution, trypsinized, and analyzed
by flow cytometry with the assistance of the Boston
University Analytical Core (LSRII Flow Cytometer; BD
Biosciences).
Inflammatory Cell Quantitation by Flow
Cytometry
Methods for quantitation of inflammatory cells in the aorta
were adapted from Moore et al.20 Briefly, nondissected
thoracic aortas from AngII-treated WT (n=5) and SMKO
(n=4) mice were isolated and manually minced with fine
scissors. Aortas were enzymatically digested for 40 minutes
A
B
Figure 2. Specific Cre-recombinase expression in VSM. Representative pictures from tissues of a Tomato
reporter mouse. A, From top to bottom: green (EGFP-Tomato) and red (Red-Tomato) fluorescence in aorta
(910), renal and mesenteric arterioles (920) of SM22a-Cre (left) and SM22a-Cre+ (right) mice. B, Specific
Cre-recombinase expression achieved in VSM of aorta (magnified in top panel, 940) and arteries of
indicated tissues but not in their parenchyma (94). Red fluorescence signal indicates Cre cells and green
fluorescence indicates Cre+ cells. EGFP indicates enhanced green fluorescent protein; SM22a, smooth
muscle 22a protein; VSM, vascular smooth muscle; WT, wild type.
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at 37°C under gentle agitation with a mixture of collage-
nases type IX and type I-S and hyaluronidase I-S dissolved
in PBS containing Ca++ and Mg++. Cell debris and
undigested material were removed by passing the suspen-
sion though a 70-lm cell strainer. Subsequently, 1 million
cells from each digested aorta were incubated with
fluorescently conjugated CD45 and CD11b antibodies or
isotype controls (Biolegend) in PBS containing 5% BSA for
25 minutes at 4°C, washed, and immediately analyzed by
flow cytometry (LSRII Flow Cytometer, Boston University
Flow Cytometry Core). Data are expressed as the average
of percentage of CD45+CD11b+ cells from triplicate
experiments.
Echocardiography to Assess Left Ventricular
Function
Cardiac function of WT (n=4) and SMKO (n=5) mice aged 8
weeks was assessed by echocardiography (VisualSonics
Vevo770, Toronto, Canada). Mice were lightly anesthetized
with isofluorane/O2 to keep heart rates in the range of 400
to 500 beats per minute. Left ventricular ejection fraction
and fractional shortening were measured with the left
ventricular wall trace measurement tool (Vevo770 v3.0
software; VisualSonics) from M-mode images acquired from
a left parasternal short-axis view at the level of the papillary
muscles.
A
B
C
Figure 3. SirT1 deletion in SMKO is specific for the aortic media. A, Representative Western blot for WT
and exon 4/ SirT1 in aortic media and adventitia from WT and SMKO (KO) mice. Adventitia did not express
either the deleted variant (exon 4/ SirT1) or the smooth muscle marker SM22a before or after AngII. Each
lane represents 1 mouse. n=4 for each experimental group. B, Percentages of EF and FS measured by
echocardiography in lightly anesthetized WT (n=4) and SMKO mice (n=5) and HW/TL (in mg/mm) in saline-
and AngII-treated WT and SMKO mice (n=4 in each group). *P<0.05 vs saline. C, Representative image of
triplicate Western blots for acetylated p53 of WT and SMKO VSM cell homogenates IP with an anti–acetyl
lysine antibody, indicative of SirT1 activity. 10% input, whole cell lysates without IP. AngII indicates
angiotensin II; EF, ejection fraction; Ex, exon; FS, fractional shortening; HW/TL, heart weight/tibia length
ratio; IP, immunoprecipitated; K, lysine; KO, smooth muscle SirT1 knock out; SirT1, sirtuin-1; SM22a, smooth
muscle 22a protein; WT, wild type.
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Statistical Analysis
All data are expressed as meanSEM and analyzed by
Student t test or by 1-way ANOVA to compare means of
controls and experimental groups. If data were not normally
distributed, Kruskal–Wallis with Dunn’s multiple comparisons
post test was used. Repeated measures of blood pressure
over time were analyzed by 1-way ANOVA with Dunnett’s
multiple comparisons post hoc test. Kaplan–Meier survival
curves with Wilcoxon post hoc test were used to assess the
mortality of mice in different experimental groups. One-sided
Wilcoxon rank-sum test was used to analyze dispersion of
elastin by multiphoton autofluorescence. P values <0.05 were
considered significant.
Results
AngII-Treated VSM SMKO Mice Die of Aortic
Dissection
To evaluate the role of VSM SirT1 in AngII-induced aortic
remodeling, we generated a mouse with a SirT1 exon 4
deletion specifically in VSM (SMKO) and confirmed the
deletion of functional SirT1 using both quantitative RT-PCR
and Western blot of aortic media, adventitia, and cultured
aortic VSM cells. Consistent with previous reports in other
tissues,21,22 we found that SirT1 mRNA was decreased by
99% in aorta of SMKO mice compared with WT mice
(Figure 1A). SMKO aortic media produced a truncated SirT1
protein with an apparent molecular mass 7 kDa lower than
WT SirT1 that lacked the functional deacetylase domain
(Figure 1B). We further confirmed the deletion in smooth
muscle of aorta and other vessels, but not in the parenchyma
of major organs, by intercrossing SM22a-Cre with a Tomato
reporter mouse (Figure 2). Adventitial fibroblasts may acquire
a myofibroblast (SM22a+) phenotype in response to increased
aortic wall stresses because the adventitia becomes a major
load-bearing component of the arterial wall under high
pressures. Although the truncated SirT1 protein was not
present in the adventitia of SMKO mice, we explored the
possibility that, in response to AngII, SM22a+ myofibroblast
might start expressing Cre-recombinase, resulting in SirT1
deletion in adventitia; however, neither SM22a nor the exon
4–deleted SirT1 variant were detected in the adventitia after
AngII in SMKO mice, confirming the deletion for the aortic
A
C
B
Figure 4. In response to AngII, SMKO mice die of aortic dissection. A, Survival curves of WT and SMKO
(KO) mice over a 14-day course of AngII infusion. Number of mice indicated in parenthesis. *P<0.05 vs WT.
B, Representative pictures of aortas from saline- and AngII-treated WT and SMKO (KO) mice. Aortic
dissections are evident in AngII-treated SMKO mice. Arrowheads indicate the point of aortic wall tearing. C,
Representative pictures of a dissected aorta from an AngII-treated SMKO mouse, viewed through the
longitudinal axis. True and false aortic lumens are highlighted with dashed lines (left). False lumen filled with
blood, as confirmed by Masson’s trichrome staining on aortic sections (94, right). AngII indicates
angiotensin II; KO, smooth muscle sirtuin-1 knockout; WT, wild type.
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media (Figure 3A). In addition, although SM22a expression is
restricted to smooth muscle lineage during late embryonic
stages and throughout adulthood, SM22a could be expressed
in cardiac myocytes during early embryogenesis.23 SMKO
mice, however, had cardiac ejection fractions and fractional
shortenings (assessed by echocardiography) and heart
weight/tibia length ratios (Figure 3B) and heart rates com-
parable to WT littermates, indicating a normal cardiac
phenotype.
To confirm a decrease in SirT1 deacetylase activity in
our novel mouse strain, we assessed the levels of
acetylated p53, a proapoptotic transcription factor with
activity inhibited by SirT1-mediated deacetylation.21 Acety-
lated p53 was significantly increased in VSM cells from
SMKO aortas compared with WT (Figure 3C), consistent
with decreased SirT1 activity in VSM of our novel murine
model.
To evaluate the role of VSM SirT1 in aortic remodeling, a
hypertensive dose of AngII (1 mg/kg per day) was adminis-
tered to WT and SMKO mice for 14 days using osmotic
minipumps. AngII strikingly increased mortality in SMKO mice
beginning as early as day 5 of treatment, with 50% of mice
dying within 9 days and only 30% surviving until day 14
(Figure 4A). On necropsy, mice that spontaneously died or
A
B C D
E F
Figure 5. Vasoconstrictor responses in WT and SMKO mice. Blood pressures (A) and HRs (B) measured
by radiotelemeters in conscious WT and SMKO mice before (baseline) and during 5 days (D1 to D5) of AngII
infusions (1 mg/kg per day). n=5 in each group; *P<0.05 vs WT. Quantitative RT-PCR of aortic (C) and
mesenteric (D) artery mRNA extracts from saline- and AngII-treated WT and SMKO mice (n=7, WT/saline;
n=8, SMKO/saline; n=9, WT/AngII; n=9 SMKO/AngII). *P<0.05 vs WT/saline, †P<0.05 vs WT/AngII, by
Kruskal–Wallis test with Dunn’s post test. Data are normalized to endogenous b-actin and, for mesenteric
arteries, expressed as ratio of the vascular smooth muscle–specific marker MYH11. E, Blood pressures
measured by intra-arterial (carotid artery) pressure catheters in anesthetized WT and SMKO mice before
and after an intravenous bolus of phenylephrine (100 lL, 1 mmol/L). n=4 in each group; *P<0.05 vs
baseline. F, Pressure responses to norepinephrine infusions (10 mg/kg per day) in WT and SMKO mice
measured by radiotelemetry. n=4 in each group. *P<0.05 vs WT. AngII indicates angiotensin II; AT1R, AngII
receptor type 1; D, day; DBP, diastolic blood pressure; HR, heart rate; MAP, mean arterial pressure; MYH11,
myosin heavy chain 11; SBP, systolic blood pressure; SMKO, smooth muscle sirtuin-1 knockout; WT, wild
type.
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required euthanasia had blood in either the thoracic or
abdominal cavity. Thrombosis was evident in the aortic wall in
the thoracic or abdominal region and, in some cases, in both
regions (Figure 4B and 4C).
Considering that hypertension is a major risk factor for an
aortic dissection,24 we determined whether SMKO mice had
an exaggerated hypertensive response to AngII by monitoring
the development of AngII-induced hypertension with
radiotelemeters. Although WT and SMKO mice have similar
baseline systolic, mean, and diastolic blood pressures
(Figure 5A) and heart rates (Figure 5B), the hypertensive
response to AngII was significantly attenuated in SMKO mice
(Figure 5A). In an attempt to explain the blunted hypertensive
response to AngII in SMKO, and because it has been reported
previously that SirT1 regulates AT1R expression in cultured
VSM cells,25 we analyzed AT1R mRNA levels in aortas and
mesenteric arteries by quantitative RT-PCR. At baseline, there
was no difference in AT1R mRNA between WT and SMKO;
however, AngII increased AT1R mRNA in WT but not in SMKO
arteries, suggesting that the lower hypertensive response to
AngII in SMKO mice may be due to decreased expression of
AT1R (Figure 5C and 5D).
We further characterized the pressure response to other
vasoconstrictors using high-fidelity pressure catheters
inserted into the carotid artery of anesthetized mice. Baseline
mean arterial pressure and the pressure response to an
intravenous bolus of phenylephrine (100 lL, 1 mmol/L) were
comparable in WT and SMKO littermates (Figure 5E), sug-
gesting that SirT1 deficiency in VSM does not induce a
generalized effect on vasopressor responses. Moreover, the
dramatic incidence of aortic dissection in SMKO mice given
AngII was not a mere consequence of increased hemody-
namic load on the aorta because an equipotent dose of
norepinephrine (10 mg/kg per day) increased blood pressure
to the same extent as did AngII and in WT mice (Figure 5F), as
measured by radiotelemetry, but failed to cause aortic
dissections in any of SMKO mice (0 of 5).
Structural and Mechanical Changes in SMKO
Aorta in Response to AngII
There was no apparent alteration in the number or organiza-
tion of aortic elastic lamellae in SMKO aortas, excluding a
developmental elastin defect in SMKO mice; however, follow-
ing AngII, SMKO aortas showed disordered elastic lamellae
with frequent elastin breaks (Figure 6A) and decreased medial
hypertrophy (Table). An assessment of elastin microstructure
by multiphoton microscopy16 at multiple locations along the
aorta revealed typical parallel microstructure of elastin fibers
in each elastic lamellae in SMKO mice at baseline, similar to
WT littermates. After AngII, the elastin fiber network appeared
disorganized in SMKO aortas and demonstrated significantly
A
B
Figure 6. AngII causes elastin fragmentation in SMKO aortas. Representative pictures of elastin-stained
(Van Gieson) aortic sections (920) (A) and elastin fiber microstructure by multiphoton microscopy (green:
elastin, blue: collagen; image width: 306 lm) (B) from saline- and AngII-treated WT and SMKO mice.
Descending aortas are displayed. C, Quantification of elastin microstructure from saline- and AngII-treated
WT and SMKO mice (1-sided Wilcoxon rank-sum test, *P<0.05 vs WT/AngII; n=4, WT/saline; n=4, SMKO/
saline; n=5, WT/AngII; n=5, SMKO/AngII) based on the elastin fiber dispersion in the descending aorta.
AngII indicates angiotensin II; SMKO, smooth muscle SirT1 knockout; WT, wild type.
Table. Lack of VSM SirT1 Prevents AngII-Induced Aortic
Hypertrophy
Medial Thickness Saline AngII
WT 51.61.1 lm 67.03.0 lm*
SMKO 51.00.2 lm 54.83.2 lm†
Medial thickness (in microns) measured in saline- and AngII-treated WT and SMKO
aortas: n=8, WT/saline; n=7, SMKO/saline; n=10, WT/AngII; n=7, SMKO/AngII. AngII
indicates angiotensin II; SMKO, smooth muscle sirtuin-1 knockout; WT, wild type.
*P<0.05 vs WT/saline.
†P<0.05 vs WT/AngII.
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increased dispersion, indicative of fragmentation and disrup-
tion (Figure 6B and 6C).
To evaluate the biomechanical properties of the aortic
wall in WT and SMKO aortas, with and without AngII, we
used an ex vivo measure of arterial stiffness in viable aortic
rings from segments of the aorta that had no apparent
dissection. Baseline arterial stiffness did not differ between
SMKO and WT mice but was significantly increased after
5 days of AngII in SMKO aortas (Figure 7A), as expected in
aortas with disorganized elastin.26 Consistent with ex vivo
measurements, pulse wave velocity—an in vivo index of
arterial stiffness measured in anesthetized mice at a
comparable range of mean arterial pressure—was signifi-
cantly increased in SMKO mice treated with AngII for 5 days
(Figure 7B).
Molecular Mechanisms of Aortic Dissection in
AngII-Treated SMKO Mice
To start understanding the molecular mechanisms by which
VSM SirT1 deficiency may lead to elastin fragmentation and
aortic dissection, we assessed the expression and activity of
MMPs, major elastin-degrading enzymes in the extracellular
matrix, on isolated aortic extracts after 5 days of AngII, before
any deaths occurred. Among various MMPs tested (MMP2,
MMP3, MMP9, MMP19), MMP2 and MMP9 mRNA expression
in isolated VSM cell extracts were significantly higher in
SMKO than WT extracts at baseline. In vitro treatment of VSM
cells with AngII (100 nmol/L, 6 hours) increased MMP2 and
MMP9 mRNA in both WT and SMKO extracts but to a
significantly greater extent in SMKO (Figure 8A). In-gel
zymography of whole aortic extracts showed a significant
increase in activities of MMP2 and MMP9 in SMKO extracts,
A B
Figure 7. Mechanical properties of SMKO aortas. A, Mechanical
ex vivo testing of viable, nondissected aortic rings from saline- or
AngII-treated WT and SMKO mice. n=4, WT/saline; n=4, SMKO/
saline; n=5, WT/AngII; n=5, SMKO/AngII. B, Aortic stiffness
assessed in vivo by PWV, expressed in meters per second.
*P<0.05 vs saline; †P<0.05 vs WT/AngII. n=4 in each group. AngII
indicates angiotensin II; PWV, pulse wave velocity; SMKO, smooth
muscle sirtuin-1 knockout; WT, wild type.
A B
Figure 8. VSM SirT1 prevents MMP activation in the aorta. A, MMP2 and MMP9 mRNA levels
assessed by quantitative RT-PCR in cultured VSM cells from WT and SMKO (KO) aortas, with or without
AngII (100 nmol/L, 6 hours; n=3 in each group, in duplicate experiments). *P<0.05 vs no-AngII control;
†P<0.05 vs WT/AngII. MMP2 and MMP9 mRNA expressed as fold change vs WT/no-AngII control. B,
Representative images of in-gel zymography indicative of MMP activities in aortas and their culture
medium from saline- or AngII-treated WT and SMKO mice and mice overexpressing SirT1 in VSM (Tg).
Each lane represents 1 mouse; n=4 in each group. AngII indicates angiotensin II; kDa, kiloDalton; MMP,
matrix metalloproteinase; SMKO, smooth muscle SirT1 knockout; WT, wild type.
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particularly when assessed in the medium of cultured aortas
(Figure 8B, top panel). Increases in MMP2 and MMP9 did not
occur in mice overexpressing SirT1 in VSM (SMTg) (Figure 8B,
bottom panel).
Because oxidants play an important role in the response of
the aortic wall to AngII and MMP activation, we measured
ROS on freshly frozen aortic sections, which indicated greater
oxidant production in aortas of AngII-treated SMKO mice
compared with AngII-treated WT mice (Figure 9A and quan-
titation in graph). Similarly, lack of SirT1 in VSM enhanced
AngII-induced oxidant production in cultured VSM cells, as
assessed by flow cytometry (Figure 9B). Incubation of
cultured aortas with tempol (10 mmol/L), an oxidant scav-
enger, completely prevented AngII-induced MMP activation
(Figure 9C).
Tissue inhibitor of metalloproteinase-1 (TIMP-1) is an
endogenous inhibitor of MMP activity and is regulated by
SirT1 in lung fibroblasts.27 TIMP-1 expression was impaired in
A
B C
D
Figure 9. AngII-stimulated oxidant production in SMKO aortas and VSM cells is responsible for MMP
activation. A, Representative pictures of DHE-stained aortic sections from WT and SMKO mice 3 days after
AngII infusion (n=7, WT/saline; n=5, SMKO/saline; n=5, WT/AngII; n=12, SMKO/AngII), quantified in
graph. *P<0.05 vs WT/saline; †P<0.05 vs WT/AngII, #P<0.05 vs SMKO/AngII. B, Oxidant production,
mainly superoxide, detected by DHE fluorescence and flow cytometry in cultured VSM cells from WT and
SMKO mice and treated with AngII. n=3 in each group, in duplicate experiments; *P<0.05 vs WT/no AngII;
†P<0.05 vs WT/AngII. Tiron (10 mmol/L), a superoxide scavenger, was used to demonstrate specificity of
DHE fluorescence in both cells and aortic sections. C, The oxidant scavenger tempol (10 mmol/L) prevents
AngII-stimulated MMP activation in cultured aorta, measured by in-gel zymography; each lane represents 1
mouse in duplicate experiments. D, Representative image of triplicate Western blots for TIMP-1 from aortic
homogenates of indicated mice; each lane represents 1 mouse. Band-intensity quantitation, normalized to
b-actin, and expressed as arbitrary units (AU) in graph; *P<0.05 vs WT/no AngII; †P<0.05 vs WT/AngII.
AngII indicates angiotensin II; DHE, dihydroethidine; KO or SMKO, smooth muscle SirT1 knockout; MMP,
matrix metalloproteinases; TIMP-1, tissue inhibitor of metalloproteinase-1; VSM, vascular smooth muscle;
WT, wild type.
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SMKO aortas in both saline- and AngII-treated mice compared
with WT aortas (Figure 9D and quantitation in graph).
Inflammatory cells that are resident or recruited in the
aortic wall in response to AngII may contribute to increased
oxidant production and MMP activity, leading to aortic
dissection. After 5 days of AngII, SMKO aortas had numbers
of CD45+CD11b+ cells, assessed by flow cytometry (Fig-
ure 10A), and expression of the macrophage marker galectin-
3 and the adhesion molecule VCAM-1 (Figure 10B) compara-
ble to WT littermates.
Discussion
SirT1 is an evolutionarily conserved enzyme that deacetylates
multiple intracellular targets and is important for a variety of
cellular functions such as DNA damage repair, cell cycle
regulation, apoptosis, senescence, and adaptation to meta-
bolic stress. In the present study, we investigated the role of
endogenous SirT1 in VSM during AngII infusion, using a novel
mouse model lacking functional SirT1 in VSM (SMKO). We
found that aortas lacking SirT1 in smooth muscle cells,
although structurally and functionally not different from WT
littermates at baseline, were prone to aortic dissections after
modest doses of AngII (1 mg/kg per day), with only 30% of
SMKO mice surviving a 14-day AngII treatment. In SMKO
mice, blood pressures at baseline and after a-adrenergic
agonists were not different than those in WT mice, indicating
that lack of SirT1 in VSM does not affect peripheral vascular
resistance or a-adrenergic vasoconstriction responses.
Nonetheless, after even brief exposure to AngII (5 days),
42% (24 of 56) of the SMKO mice were alive but with
dissected aortas. This was associated with increased oxidant
production and MMP activities, leading to severe elastin
fragmentation compared with WT. Our findings strongly
implicate a requirement of the aortic wall for VSM SirT1 to
maintain structural and functional integrity and to prevent
aortic dissection by preventing matrix metalloproteinase
activation and elastin fragmentation.
Notably, AngII-induced aortic dissections in SMKO mice
were not a mere consequence of increased hemodynamic
stress on the aortic wall because (1) AngII-induced hyperten-
sion was blunted in SMKO mice compared with WT mice and
(2) a hypertensive dose of norepinephrine—a vasoconstrictor
that, compared with AngII, does not induce inflammation and
oxidant production in the vasculature28—did not cause aortic
dissections despite systolic blood pressure increases similar
to those caused by AngII in the SMKO mice. A blunted
hypertensive response of SMKO mice to AngII appears to be
due to a failure of SMKO arteries to upregulate AT1R in
response to AngII infusion (Figure 5C and 5D). A recent study
demonstrated involvement of SirT1 in AT1R promoter regu-
lation using cultured VSM cells,25 but the mechanisms by
which SirT1 regulates AT1R in vivo warrant further investiga-
tion.
In our study, MMP activation in response to AngII was
prevented in mice overexpressing SirT1 in VSM, pointing to
MMP as a VSM SirT1 downstream target and the cause of
elastolysis and aortic dissection. SirT1 negatively regulates
MMP gene transcription and activity via multiple mechanisms,
namely, by deacetylating nuclear factor jB29,30 and TIMP-1,27
an endogenous MMP antagonist. Both saline- and AngII-
treated aortas of SMKO mice had significantly lower TIMP-1
protein expression compared with WT mice (Figure 9D). In
addition, MMPs are posttranscriptionally activated by ROS,
mainly by glutathionylation of cysteine residues in the active
site.31 SirT1 deficiency in VSM was associated with increased
ROS production, as assessed in AngII-treated SMKO VSM
cells and aortic sections (Figure 9A and 9B). This is consistent
with the fact that SirT1 boosts the cellular antioxidant
capacity by directly stimulating nuclear factor E2-related
factor 2,32 a transcription factor that induces the expression
of 2 potent oxidant-scavenging enzymes (hemoxygenase-1
and superoxide dismutase), and by modulating FOXO and
p66shc.8,33 To the extent that MMPs are activated by ROS,
excessive ROS on AngII infusion and in settings of SirT1
deficiency might also have contributed to MMP activation in
A
B
Figure 10. Inflammatory cell infiltration in the aorta after
AngII. A, % CD45+CD11b+ cells in aortic homogenates from WT
(n=5) and SMKO (n=4) mice after 5 days of AngII treatment,
quantified by flow cytometry. B, Representative Western blot for
galectin-3, a marker of activated macrophages, and the
adhesion molecule VCAM-1 in aortic homogenates. Each lane
represents 1 mouse in triplicate Western blots. Quantitation of
band intensities is expressed in arbitrary units (AU) in graphs.
*P<0.05 vs saline. AngII indicates angiotensin II; SMKO, smooth
muscle sirtuin-1 knockout; WT, wild type.
DOI: 10.1161/JAHA.115.002384 Journal of the American Heart Association 13
Sirtuin-1 Prevents Aortic Dissection With AngII Fry et al
O
R
IG
IN
A
L
R
E
S
E
A
R
C
H
SMKO aortas, as corroborated by the fact that tempol (an
oxidant scavenger) was able to completely prevent AngII-
induced MMP activation (Figure 9C). Notably, although struc-
turally normal at baseline, SMKO aortas are primed for
activation of MMPs, as indicated by an increase in baseline
MMP mRNA expression and oxidants. It is likely that SirT1
regulates multiple factors responsible for alterations in MMP
mRNA and protein expression, oxidant production, and
scavenging and for MMP activity responsible for elastin
breakdown, increased stiffness, and dissection of the aorta,
despite lower blood pressure.
Considering that activation and infiltration of inflammatory
cells in the aorta is a hallmark of this model of AngII
hypertension,34 we cannot exclude a contribution of inflam-
matory cells to oxidant production and MMP activation in
aortas of AngII-treated mice; however, our study indicated
that the exaggerated oxidant production and MMP activities in
SMKO aortas leading to aortic dissection are not due to
increased recruitment of inflammatory cells in aortas lacking
VSM SirT1 compared with WT aortas after AngII.
Aortic dissection is a life-threatening condition for which
treatment options are currently limited. Our study demon-
strates that VSM SirT1 is a crucial requirement for vessel
integrity and for preventing aortic dissection in settings of
AngII hypertension. Of note, a recent study used the same
VSM SirT1 knockout mice as ours and reported that the mice,
when on an apolipoprotein E–null background and fed an
atherogenic diet, were prone to atherosclerotic plaque
formation to a greater extent than controls. Interestingly, in
2 of 12 mice studied, medial degeneration and elastin
fragmentation were evident in atherosclerotic lesions and
associated with aortic aneurysm and dissection.10 Although
the authors underscored that these pathological features
were observed only in 16% of mice with apolipoprotein E
deletion and concomitant fat feeding but not in controls, their
data pointed to a broader protective role of VSM SirT1 against
aortic media tearing and dissection. Furthermore, resveratrol,
a natural polyphenol known to activate SirT1, has recently
been shown to prevent arterial remodeling and stiffening in
mice35,36 and in nonhuman primates.37 Consequently,
polyphenols and specific SirT1 activators could be attractive
therapeutic approaches against aortic dissections or rupture
in patients at risk, such as hypertensive persons or those with
Marfan’s syndrome and related disorders.
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